Log in

CVE:IOTInnovotech Stock Price, Forecast & News

C$0.18
0.00 (0.00 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
C$0.18
Now: C$0.18
C$0.18
50-Day Range
C$0.15
MA: C$0.18
C$0.22
52-Week Range
C$0.05
Now: C$0.18
C$0.28
VolumeN/A
Average Volume44,305 shs
Market CapitalizationC$6.52 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Innovotech Inc. provides services and solutions to medical, agricultural, and industrial problems caused by microbial biofilms in Canada and internationally. The company's products include InnovoSIL, the antimicrobial agents for coating onto or incorporation into medical devices; MBEC Assay, a screening assay used to determine the efficacy of antimicrobials against biofilms of various microorganisms; and Agress/AgreGuard, an environmentally friendly seed treatments and plant sprays to protect crops against both bacterial and fungal infections. Its products also include MBEC Assay's biofilm inoculator comprising plastic lids with 96 pegs to simulate the surface conditions on which microorganisms attach and grow. The company's services cover implant medical devices, bacteriophage and cytotoxicity testing, and in vitro antimicrobial testing, as well as antibiotic, antimicrobial, and biocide resistance. It serves customers in the areas of biofilm issues, including catheter and implant medical devices, antibiotic drug development, wound healing, paint and specialized coatings, water system antimicrobial agents, dental treatments and water line antimicrobial agents, and bacterial and fungal agricultural crop diseases, as well as disinfectants in food safety, transportation, and healthcare. The company is headquartered in Edmonton, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.06 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-780-4480585

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$890,591.00
Cash FlowC$0.00 per share

Profitability

Miscellaneous

EmployeesN/A
Market CapC$6.52 million
Next Earnings Date8/18/2020 (Estimated)
OptionableNot Optionable

Receive IOT News and Ratings via Email

Sign-up to receive the latest news and ratings for IOT and its competitors with MarketBeat's FREE daily newsletter.

Innovotech (CVE:IOT) Frequently Asked Questions

How has Innovotech's stock been impacted by COVID-19 (Coronavirus)?

Innovotech's stock was trading at C$0.12 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, IOT stock has increased by 56.5% and is now trading at C$0.18. View which stocks have been most impacted by Coronavirus.

When is Innovotech's next earnings date?

Innovotech is scheduled to release its next quarterly earnings announcement on Tuesday, August 18th 2020. View our earnings forecast for Innovotech.

Has Innovotech been receiving favorable news coverage?

News coverage about IOT stock has trended somewhat negative on Saturday, according to InfoTrie. The research group rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Innovotech earned a news sentiment score of -1.0 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the next several days. View the latest news about Innovotech.

Who are some of Innovotech's key competitors?

What other stocks do shareholders of Innovotech own?

Who are Innovotech's key executives?

Innovotech's management team includes the following people:
  • Dr. James Timourian, Chairman, CEO, Pres & Sec.
  • Mr. Alan C. Savage, CFO & Director (Age 76)
  • Dr. Amin Omar, Chief Operating Officer
  • Dr. Merle Olson, Scientific Consultant

What is Innovotech's stock symbol?

Innovotech trades on the Canadian Venture Exchange (CVE) under the ticker symbol "IOT."

How do I buy shares of Innovotech?

Shares of IOT and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Innovotech's stock price today?

One share of IOT stock can currently be purchased for approximately C$0.18.

How big of a company is Innovotech?

Innovotech has a market capitalization of C$6.52 million and generates C$890,591.00 in revenue each year.

What is Innovotech's official website?

The official website for Innovotech is www.incomeopp-realty.com.

How can I contact Innovotech?

Innovotech's mailing address is Suite 101, 2011-94 Street, EDMONTON, AB T6N 1H1, Canada. The company can be reached via phone at +1-780-4480585.

This page was last updated on 7/4/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.